CONNAUGHTON BERNADETTE sold 3.9% of their position (1.63K shares) of HALOZYME THERAPEUTICS, INC. on the open market
Open‑market sale worth $167.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/11/2026ACC: 0001662521-26-000002
Director
Since Sep 2018
-1.63K
Net shares
Net seller
$167.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.63K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.63K
Price / share
$102.80
Trade value
$167.15K
% of position
3.9%
8/10/2026
42.04K→40.42K
Total
Net shares
−1.63K
Net value
-$167.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/10/2026 | S · Sale | −1.63K | $102.80 | $167.15K | 3.9% | 42.04K | 40.42K |
| Total | −1.63K | -$167.15K | ||||||
Derivative Transactions0
No derivative transactions reported